NCT03198000View on ClinicalTrials.gov

A Study to Evaluate the Efficacy of Investigational OTC Eye Drops

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

June 28, 2017

Primary Completion Date

July 21, 2017

Study Completion Date

July 21, 2017

Conditions

Ophthalmic Solutions

Interventions

DRUG

F# 13418-148 Eye Drops

ocular clear liquid. Tetrahydrozoline 0.05%; Glycerin 0.40% 1-2 drops will be instilled as instructed over one day

DRUG

F#13418-158 Eye Drops

ocular clear liquid Tetrahydrozoline 0.05%; Glycerin 0.20%, Hypromellose 0.2%, Polyethylene glycol 400 1.0% 1-2 drops will be instilled as instructed over one day

DRUG

F# PF-004390 Eye Drops

Ocular clear liquid Tetrahydrozoline 0.05%; 1-2 drops will be instilled as instructed over one day

Trial Locations (1)

01810

Andover Eye Associates, Andover

All Listed Sponsors

lead

Johnson & Johnson Consumer Inc. (J&JCI)

INDUSTRY

NCT03198000 - A Study to Evaluate the Efficacy of Investigational OTC Eye Drops | Biotech Hunter | Biotech Hunter